201 related articles for article (PubMed ID: 9366317)
21. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
Kennelly MJ; Lemack GE; Foote JE; Trop CS
Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
[TBL] [Abstract][Full Text] [Related]
22. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury.
Donnellan SM; Bolton DM
BJU Int; 1999 Aug; 84(3):280-5. PubMed ID: 10468722
[TBL] [Abstract][Full Text] [Related]
23. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
[TBL] [Abstract][Full Text] [Related]
24. A cross-sectional study of the catheter management of neurogenic bladder after traumatic spinal cord injury.
Lane GI; Driscoll A; Tawfik K; Chrouser K
Neurourol Urodyn; 2018 Jan; 37(1):360-367. PubMed ID: 28580635
[TBL] [Abstract][Full Text] [Related]
25. Bladder management during pregnancy in women with spinal-cord injury: an observational, multicenter study.
Andretta E; Landi LM; Cianfrocca M; Manassero A; Risi O; Artuso G
Int Urogynecol J; 2019 Feb; 30(2):293-300. PubMed ID: 29600402
[TBL] [Abstract][Full Text] [Related]
26. Effect of Early Oxybutynin Treatment on Posterior Urethral Valve Outcomes in Infants: A Randomized Controlled Trial.
Abdelhalim A; El-Hefnawy AS; Dawaba ME; Bazeed MA; Hafez AT
J Urol; 2020 Apr; 203(4):826-831. PubMed ID: 31821098
[TBL] [Abstract][Full Text] [Related]
27. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
[TBL] [Abstract][Full Text] [Related]
28. [Quality of life evaluation in spinal cord injured patients comparing different bladder management techniques].
Sánchez Raya J; Romero Culleres G; González Viejo MA; Ramírez Garcerán L; García Fernández L; Conejero Sugrañes J
Actas Urol Esp; 2010 Jun; 34(6):537-42. PubMed ID: 20510117
[TBL] [Abstract][Full Text] [Related]
29. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder - a hypothesis.
Vaidyanathan S; Mansour P; Soni BM; Singh G; Sett P
BMC Urol; 2002 Apr; 2():5. PubMed ID: 11980583
[TBL] [Abstract][Full Text] [Related]
30. To clamp or not to clamp? Bladder management by suprapubic catheterization in patients with neurogenic bladder dysfunction.
Pannek J; Göcking K; Bersch U
World J Urol; 2010 Oct; 28(5):637-41. PubMed ID: 20049456
[TBL] [Abstract][Full Text] [Related]
31. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
Wada N; Shimizu T; Takai S; Shimizu N; Tyagi P; Kakizaki H; Yoshimura N
Neurourol Urodyn; 2017 Apr; 36(4):1039-1045. PubMed ID: 27367752
[TBL] [Abstract][Full Text] [Related]
32. Long-term urologic management of the patient with spinal cord injury.
Perkash I
Urol Clin North Am; 1993 Aug; 20(3):423-34. PubMed ID: 8351768
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of Hydrastis for the prevention of encrustation of long-term indwelling catheters in persons with neurogenic bladder dysfunction: a case series.
Pannek J; Pannek-Rademacher S
Spinal Cord Ser Cases; 2021 Jul; 7(1):66. PubMed ID: 34326303
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of combined oral-intravesical oxybutynin hydrochloride treatment for patients with overactive detrusors and indwelling urethral catheters.
Ersoz M; Yildiz N; Akyuz M; Koseoglu F
Rehabil Nurs; 2010; 35(2):80-6. PubMed ID: 20306617
[TBL] [Abstract][Full Text] [Related]
35. Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida - a randomized controlled study.
Dash V; Bawa M; Mahajan JK; Kanojia RP; Samujh R; Rao KL
J Pediatr Surg; 2016 Dec; 51(12):2025-2029. PubMed ID: 27680597
[TBL] [Abstract][Full Text] [Related]
36. Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder.
Malik MF; Randall JH; Campbell JG; McLaughlin MJ; Koenig JF
Top Spinal Cord Inj Rehabil; 2022; 28(3):9-14. PubMed ID: 36017125
[TBL] [Abstract][Full Text] [Related]
37. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury.
Nosseir M; Hinkel A; Pannek J
Neurourol Urodyn; 2007; 26(2):228-33. PubMed ID: 16998859
[TBL] [Abstract][Full Text] [Related]
38. Influences on renal function in chronic spinal cord injured patients.
Weld KJ; Wall BM; Mangold TA; Steere EL; Dmochowski RR
J Urol; 2000 Nov; 164(5):1490-3. PubMed ID: 11025689
[TBL] [Abstract][Full Text] [Related]
39. The female tetraplegic: an admission of urological failure.
Singh G; Thomas DG
Br J Urol; 1997 May; 79(5):708-12. PubMed ID: 9158506
[TBL] [Abstract][Full Text] [Related]
40. Role of chronic catheterization in the development of bladder cancer in patients with spinal cord injury.
West DA; Cummings JM; Longo WE; Virgo KS; Johnson FE; Parra RO
Urology; 1999 Feb; 53(2):292-7. PubMed ID: 9933042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
